About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

BioNexus Gene Lab Corp. Regains Nasdaq Compliance, Signaling Strategic Stability and Growth Readiness

KUALA LUMPUR, Malaysia, April 30, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (Nasdaq: BGLC), a biotechnology company specializing in precision diagnostics and specialty chemical solutions, today announced that it has received official notification from The Nasdaq Stock Market LLC ("Nasdaq") confirming the Company has regained full compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share.

This important milestone reaffirms the Company’s standing as a compliant and growth-focused public company. It marks the successful conclusion of a focused compliance initiative and paves the way for the Company to pursue its bold innovation roadmap, capital market engagement, and international expansion.

“This achievement is more than a compliance milestone - it’s a signal to the market that BGLC is strategically aligned, financially resilient, and fully prepared to capitalize on future growth opportunities,” said Sam Tan, Chief Executive Officer of BioNexus Gene Lab Corp. “Our Nasdaq listing continues to be a cornerstone of our long-term strategy, enabling global visibility, investor confidence, and access to institutional capital. We’re excited to move forward from this position of strength.”

A Platform for Innovation and Global Reach

BioNexus Gene Lab Corp. is advancing a multi-pronged strategy centered on:

  • Expanding its RNA-based genomic diagnostics business, MRNA Scientific, including strategic partnerships and the potential to bring on new products, and driving adoption of its non-invasive blood tests that screen for 11 major diseases.
  • Scaling its specialty materials subsidiary, Chemrex, which currently serves Southeast Asia’s growing demand for high-performance chemical raw materials, into new areas of sustainable development, and growth in upstream and downstream production.

Reinforced Corporate Governance and Market Readiness

In parallel with achieving Nasdaq compliance, BGLC has taken decisive steps to strengthen corporate governance, enhance internal controls, and position itself for strategic partnerships, capital raising, and M&A activity. This includes the appointment of new independent board members, the formation of a dedicated internal audit function, and the retention of U.S.-based investment banking support for long-term value creation initiatives.

“Our continued Nasdaq listing reflects our governance maturity and sets the foundation for scaling BGLC into a regionally integrated, innovation-driven enterprise,” said Tan. “We are grateful to our shareholders, advisors, and team members for their continued belief in our vision.”

About BioNexus Gene Lab Corp.

BioNexus Gene Lab Corp. (Nasdaq: BGLC) is a Wyoming-incorporated biotechnology and specialty materials company with operations across Malaysia and Southeast Asia. The Company is a pioneer in RNA-based blood diagnostics, and a leading supplier of industrial chemical raw materials. BGLC is committed to delivering cutting-edge healthcare diagnostics, sustainable materials, and digital asset innovation to improve lives and build shareholder value.

For more information, visit: www.bionexusgenelab.com

Investor Relations Contact:
Email: ir@bionexusgenelab.com
Phone: +1 307 241 6898


Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.